Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,529 | -1,020 | -382 | -206 | -95 |
| Depreciation Amortization | 75 | 2 | 1 | 0 | 0 |
| Accounts receivable | -52 | -38 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 248 | -255 | -58 | -77 | 93 |
| Other Working Capital | 41 | -423 | -260 | -177 | -62 |
| Other Operating Activity | -98 | 119 | -100 | 139 | -93 |
| Operating Cash Flow | $-2,314 | $-1,614 | $-799 | $-320 | $-158 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -666 | -222 | -8 | N/A | -2 |
| Other Investing Activity | 306 | 306 | 0 | 0 | 0 |
| Investing Cash Flow | $-360 | $84 | $-8 | $N/A | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,871 | 10,015 | 9,783 | 394 | 1,515 |
| Financing Cash Flow | $9,871 | $10,015 | $9,783 | $394 | $1,515 |
| Beginning Cash Position | 1,355 | 1,355 | 1,355 | 1,355 | N/A |
| End Cash Position | 8,553 | 9,840 | 10,331 | 1,429 | 1,355 |
| Net Cash Flow | $7,197 | $8,484 | $8,975 | $73 | $1,355 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,314 | -1,614 | -799 | -320 | -158 |
| Capital Expenditure | -666 | -222 | -8 | N/A | -2 |
| Free Cash Flow | -2,980 | -1,836 | -807 | -320 | -160 |